These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 29804909)

  • 1. Familial chylomicronemia syndrome: Bringing to life dietary recommendations throughout the life span.
    Williams L; Rhodes KS; Karmally W; Welstead LA; Alexander L; Sutton L;
    J Clin Lipidol; 2018; 12(4):908-919. PubMed ID: 29804909
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Familial Chylomicronemia Syndrome: A Clinical Guide For Endocrinologists.
    Falko JM
    Endocr Pract; 2018 Aug; 24(8):756-763. PubMed ID: 30183397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The burden of familial chylomicronemia syndrome: Results from the global IN-FOCUS study.
    Davidson M; Stevenson M; Hsieh A; Ahmad Z; Roeters van Lennep J; Crowson C; Witztum JL
    J Clin Lipidol; 2018; 12(4):898-907.e2. PubMed ID: 29784572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Familial chylomicronemia syndrome: A rare but devastating autosomal recessive disorder characterized by refractory hypertriglyceridemia and recurrent pancreatitis.
    Chyzhyk V; Brown AS
    Trends Cardiovasc Med; 2020 Feb; 30(2):80-85. PubMed ID: 31003756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The burden of familial chylomicronemia syndrome in Canadian patients.
    Gaudet D; Stevenson M; Komari N; Trentin G; Crowson C; Hadker N; Bernard S
    Lipids Health Dis; 2020 Jun; 19(1):120. PubMed ID: 32487261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The burden of familial chylomicronemia syndrome from the patients' perspective.
    Gelrud A; Williams KR; Hsieh A; Gwosdow AR; Gilstrap A; Brown A
    Expert Rev Cardiovasc Ther; 2017 Nov; 15(11):879-887. PubMed ID: 28847199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Familial chylomicronemia syndrome: an under-recognized cause of severe hypertriglyceridaemia.
    Baass A; Paquette M; Bernard S; Hegele RA
    J Intern Med; 2020 Apr; 287(4):340-348. PubMed ID: 31840878
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Effect of a Fat-Restricted Diet in Four Patients with Familial Chylomicronemia Syndrome: A Long-Term Follow-Up Study.
    Thajer A; Skacel G; de Gier C; Greber-Platzer S
    Children (Basel); 2021 Nov; 8(11):. PubMed ID: 34828789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Comprehensive Update on the Chylomicronemia Syndrome.
    Goldberg RB; Chait A
    Front Endocrinol (Lausanne); 2020; 11():593931. PubMed ID: 33193106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Editorial commentary: Dietary management of familial chylomicronemia syndrome.
    Williams L; Wilson DP
    J Clin Lipidol; 2016; 10(3):462-5. PubMed ID: 27206931
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical profile, genetic spectrum and therapy evaluation of 19 Chinese pediatric patients with lipoprotein lipase deficiency.
    Xia Y; Zheng W; Du T; Gong Z; Liang L; Wang R; Yang Y; Zhang K; Lu D; Chen X; Sun Y; Sun Y; Xiao B; Qiu W
    J Clin Lipidol; 2023; 17(6):808-817. PubMed ID: 37858495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterizing familial chylomicronemia syndrome: Baseline data of the APPROACH study.
    Blom DJ; O'Dea L; Digenio A; Alexander VJ; Karwatowska-Prokopczuk E; Williams KR; Hemphill L; Muñiz-Grijalvo O; Santos RD; Baum S; Witztum JL
    J Clin Lipidol; 2018; 12(5):1234-1243.e5. PubMed ID: 30318066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced psychological distress in familial chylomicronemia syndrome after patient support group intervention.
    Wilson LM; Cross RR; Duell PB
    J Clin Lipidol; 2018; 12(1):240-242. PubMed ID: 29195809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The burden of familial chylomicronemia syndrome: interim results from the IN-FOCUS study.
    Davidson M; Stevenson M; Hsieh A; Ahmad Z; Crowson C; Witztum JL
    Expert Rev Cardiovasc Ther; 2017 May; 15(5):415-423. PubMed ID: 28338353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Familial chylomicronemia syndrome and response to medium-chain triglyceride therapy in an infant with novel mutations in GPIHBP1.
    Ahmad Z; Wilson DP
    J Clin Lipidol; 2014; 8(6):635-639. PubMed ID: 25499947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of therapeutic plasma exchange in reducing the incidence of recurrent pancreatitis related to familial chylomicronemia.
    Fitts E; Lee PDK; Yates SG
    Transfusion; 2019 Nov; 59(11):3324-3328. PubMed ID: 31568575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Etiology and emerging treatments for familial chylomicronemia syndrome.
    Spagnuolo CM; Hegele RA
    Expert Rev Endocrinol Metab; 2024 Jul; 19(4):299-306. PubMed ID: 38866702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Familial chylomicronemia syndrome: pediatric experience in Argentina].
    Araujo MB; Eiberman G; Etcheverry N; Pacheco G
    Arch Argent Pediatr; 2022 Jun; 120(3):e123-e127. PubMed ID: 35533124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Familial Chylomicronemia Syndrome (FCS): Recent Data on Diagnosis and Treatment.
    Gallo A; Béliard S; D'Erasmo L; Bruckert E
    Curr Atheroscler Rep; 2020 Aug; 22(11):63. PubMed ID: 32852651
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monogenic hypertriglyceridemia and recurrent pancreatitis in a homozygous carrier of a rare APOA5 mutation: a case report.
    Makhmudova U; Schulze PC; Lorkowski S; März W; Geiling JA; Weingärtner O
    J Med Case Rep; 2024 Jun; 18(1):278. PubMed ID: 38872171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.